Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

OpenAI is preparing for an IPO potentially valuing the company at $1 trillion, aiming to file by late 2026 or early 2027.

Corporate travel and expense company Navan on Wednesday priced its initial public offering at $25 per share, within its ...

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company ...

Investors have been clamoring for ways to gain exposure to the AI powerhouse. Reuters reports that an IPO could come as soon as 2H 2026.

The company unveiled a swath of artificial intelligence-powered products on Friday in its latest bid for market share ahead ...

The Sydney-based tech firm has made its biggest product launch yet as it eyes a sharemarket float within the next two years.

OpenAI, the company behind ChatGPT, the chatbot that sparked a technological revolution with generative artificial intelligence, is preparing its stock market debut.

Navan shares fell by as much as 12% after the corporate travel and expense management software startup went public on the Nasdaq in a resurgent year for IPOs.